Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Outlook 2018: Companies Need To Quantify Brexit Risk And Find A New Place In The World

Executive Summary

With the clock running down on Brexit, bemused UK medtechs are ready to seize any information that helps them chart a way forward on trading with the EU in the absence of solid directions from the government. Frustrated by the Brexit vacuum, local manufacturers are actively looking to build businesses beyond the EU and focusing on innovation adoption at home, as ABHI policy director Richard Phillips explains.

You may also be interested in...



UK Medtechs Stress Need To Get It Right On Brexit As Prime Minister Addresses EU

Coinciding with UK prime minister Theresa May's third major speech on her Brexit vision for the UK, the local medtech industry has taken the opportunity to stress the vital need for sensible, workable trading arrangements governing UK-EU health-care supply chains after March 2019.

NHS Medtech Demand-Side Should Be Greater Priority, Says UK Industry In AAR Response

The Accelerated Access Review, part of the UK's renewed push to speed access to innovations for system efficiency, cost savings and outcomes improvements, strikes most of the right notes, but there is still room for improvement in the framework of innovation adoption by the NHS, according to an industry-commissioned response to the review.

UK Medtech Rises Up To Meet The Challenges Of Brexit

How the UK medtech industry can forge successful international relationships, increase health-care delivery efficiency and improve patient outcomes following Brexit are the challenges taken up by the Association of British Healthcare Industries in a new report.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT122164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel